LY293111
货号:
10009768-10mg 基本售价:
16856.0 元 规格:
10 mg
产品信息
概述货号 | 10009768-10mg |
描述 | Leukotriene B4(LTB4) is a dihydroxy fatty acid derived from the 5-lipoxygenase pathway of arachidonic acid metabolism and is an important mediator of the inflammatory process. LY293111 is a potent antagonist of the leukotriene B4(LTB4) receptor, BLT1, that inhibits the specific binding of radiolabeled-LTB4 to isolated human neutrophils with an IC50 value of 17.6 nM and inhibits the LTB4-induced chemotaxis of human neutrophils with an IC50 value of 6.3 nM.1 LY293111 inhibits growth of MiaPaCa-2 and AsPC-1 human pancreatic cancer cells in vitro (250-1,000 nM) and subcutaneous xenografts in athymic mice (250 mg/kg/day), inducing apoptosis and S-phase arrest.2 |
别名 | Etalocib;VML 295; |
性能供应商 | Cayman |
应用文献 |
1.Jackson, W.T.,Froelich, L.L.,Boyd, R.J., et al. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: In vitro studies. Journal of Pharmacology and Experimental Therapeutics 288(1), 286-294 (1999). 2.Tong, W.G.,Ding, X.Z.,Hennig, R., et al. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clinical Cancer Research 8, 3232-3242 (2002).
|
运输条件 | Room temperature in continental US; may vary elsewhere |
存放说明 | -20 |
纯度 | ≥98% |
计算分子量 | 543.6 |
分子式 | C33H33FO6 |
CAS号 | 161172-51-6 |
稳定性 | ≥ 2 years |
声明本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。 |